Archive for the ‘Market-Employers’ Category

Cognitive Decline at 45: Fact or Fiction?

12th February 2012 by Christian Elliott Comments Off

Several news stories have appeared in the past month regarding this research study, based on the Whitehall II cohort project, which has followed the overall health of several thousand British civil servants since 1985. Most of the news stories use mildly alarmist terms like “Mental Decline Starts at 45” and “Sorry, Boomers, but a new [...]

Brain Health Primer – Four Ways to Maintain Your Brain

31st January 2012 by Christian Elliott Comments Off

Several readers have asked about the best ways to maintain their brain health. Before laying out any money for the latest brain health supplements that are advertised on Google and other search engines, consider the basic lifestyle choices below. There is a large and growing body of research evidence that confirms these important facts on [...]

Virtual Reality and Avatars for Cognitive Testing and Rehabilitation

4th October 2011 by Christian Elliott Comments Off

The Health 2.0 conference in San Francisco and related HealthCamp SFBay “unconference” were both forward-looking meetings on where health care will be heading in the next several years. One of the themes I want to pull out and examine in more detail is the use of virtual reality (VR) and avatars for a wide range [...]

New Models for Health Care

27th September 2011 by Christian Elliott Comments Off

I’m at the Health 2.0 Conference in San Francisco this week, participating in a very interesting look at where the US health care system is heading over the next several years. There is already a torrent of information after less than a day into the conference, so I’ll pull out some nuggets to ponder: “Aetna [...]

Privacy and Ethics Challenges on Early Diagnosis of Alzheimer’s Disease

20th September 2011 by Christian Elliott Comments Off

A timely article in the medical journal Neurology speaks to some impending issues that millions of patients and physicians will be facing over the next decade, namely the possible early diagnosis of Alzheimer’s Disease in the pre-clinical phase, before functional cognitive impairment is present. New computerized cognitive testing tools and experimental biomarker tests are bringing [...]